1 Min Read
May 8 (Reuters) - MATRX PHARMACEUTICALS SA:
* Q4 2016 NET LOSS OF 4.9 MILLION ZLOTYS VERSUS PROFIT OF 80.7 MILLION ZLOTYS A YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.